IRCCS Azienda Ospedaliero-Universitaria di Bologna: Leukemia trials
The registry lists 10 Leukemia studies with IRCCS Azienda Ospedaliero-Universitaria di Bologna as lead sponsor. 8 are open to participants now and 0 have results posted.
No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Infusion of Alloreactive nk Cells for Mrd-positive Aml PatientsRecruitingNCT06885476Not applicable
- Targeting Acute Myeloid Leukemia Immunosuppressive Microenvironment by combinedIDO1 Inhibition and PD-1 BlockadeRecruitingNCT06874257
- Study of the Immunological Infiltrate and Immunometabolic Immunometabolic Profile of Patients with Acute LeukaemiaRecruitingNCT06814444
- Tumors and Respiratory System Diseases Due to Air Pollution: New Biomarkers of Exposure and EffectsRecruitingNCT06800586
- Assessment of Disease Burden in Hairy Cell LeukemiaRecruitingNCT06781515Not applicable
- Decoding the Extracellular Vesicles-driven Communication in the Microenvironment of Hairy Cell Leukemia to Improve Patient Care ManagementRecruitingNCT06774677
- Hairy Cell Leukemia: Harnessing the Full Power of Extracellular Vesicles to Improve Patient Care ManagementRecruitingNCT06764524
- Molecular Characterization of Patients With Acute Myeloid Leukemia and the Impact of Clonal Evolution in the Response to Therapeutic TreatmentsRecruitingNCT06764459
- Understanding the Role of Large Extracellular Vesicles in Lymphomas and Lymphoproliferative Disorders: the "Off the Beaten Track" Liquid BiopsyCompletedNCT06782854
- INFUSION OF ALLOREACTIVE NATURAL KILLER (NK) CELLS AS CONSOLIDATION STRATEGY FOR ACUTE MYELOID LEUKEMIA PATIENTSStatus unknownNCT03955848Not applicable